CINECA IRIS Institutional Research Information System

LOPETUSO, LORIS RICCARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 495
NA - Nord America 262
EU - Europa 255
SA - Sud America 175
AF - Africa 16
OC - Oceania 2
Totale 1.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 235
BR - Brasile 130
SG - Singapore 117
CN - Cina 112
VN - Vietnam 104
DE - Germania 99
HK - Hong Kong 82
IT - Italia 75
FR - Francia 36
KR - Corea 28
AR - Argentina 18
EC - Ecuador 14
MX - Messico 13
ID - Indonesia 11
PL - Polonia 10
BD - Bangladesh 9
CA - Canada 9
GB - Regno Unito 9
IN - India 9
NL - Olanda 7
CO - Colombia 4
PK - Pakistan 4
RU - Federazione Russa 4
MA - Marocco 3
PE - Perù 3
SN - Senegal 3
UA - Ucraina 3
UY - Uruguay 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
ES - Italia 2
IQ - Iraq 2
JP - Giappone 2
SA - Arabia Saudita 2
TR - Turchia 2
AL - Albania 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
FI - Finlandia 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
MZ - Mozambico 1
NG - Nigeria 1
NP - Nepal 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 1.205
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 94
Hong Kong 82
San Jose 81
Singapore 45
Ashburn 44
Ho Chi Minh City 37
Beijing 33
Hanoi 30
New York 29
Seoul 27
Rome 10
Chicago 9
Hillsboro 9
São Paulo 9
Mexico City 8
Milan 8
Warsaw 8
Guayaquil 6
Brasília 5
Dallas 5
Naples 5
Toronto 5
Biên Hòa 4
Bắc Ninh 4
Campinas 4
Florence 4
Los Angeles 4
Porto Alegre 4
Rio de Janeiro 4
Amsterdam 3
Bexley 3
Buffalo 3
Da Nang 3
Dakar 3
Goiânia 3
Haiphong 3
Quito 3
Ribeirão Preto 3
Roubaix 3
Tashkent 3
Bahía Blanca 2
Bari 2
Bogotá 2
Caxias do Sul 2
Council Bluffs 2
Fermo 2
Guarulhos 2
Ha Long 2
Johannesburg 2
Joinville 2
Kyiv 2
La Joya de Los Sachas 2
Lahore 2
Limburg an der Lahn 2
London 2
Manaus 2
Mendoza 2
Montevideo 2
Reston 2
Rio Grande 2
Riposto 2
Santa Clara 2
Santiago 2
Sapiranga 2
Sete Lagoas 2
Teófilo Otoni 2
Tokyo 2
Tây Ninh 2
Viamão 2
Abu Dhabi 1
Acerra 1
Afonso Cláudio 1
Afonso Cunha 1
Alegrete 1
Alta Floresta d'Oeste 1
Altinho 1
Ancol 1
Ankara 1
Aracaju 1
Araguaiana 1
Araraquara 1
Araçatuba 1
Bacau 1
Baghdad 1
Bahadurgarh 1
Bandung 1
Banjar Badung 1
Barra Bonita 1
Barranquilla 1
Barras 1
Bartlett 1
Bauru 1
Bebedouro 1
Bella Vista 1
Belo Horizonte 1
Beloslav 1
Bengkulu 1
Bergamo 1
Berisso 1
Bhopal 1
Totale 739
Salva come PNG Salva come JPEG
Nome #
Escherichia coli nissle 1917 modulate gut microbiota composition in ulcerative colitis patients 56
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 51
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 49
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 45
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 44
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 42
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 42
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 40
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 36
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 35
Psychopharmacological Therapy Positively Modulates Disease Activity in Inflammatory Bowel Disease: A Systematic Review 33
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 32
Resilience and Self-Care in Patients with Inflammatory Bowel Disease: A Multicentre Cross-Sectional Study in Outpatient Settings 32
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 31
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 27
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 27
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 27
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 22
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis 22
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19 19
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 18
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 18
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 18
Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores 17
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver 16
Assessment of neurological manifestations in hospitalized patients with COVID‐19 16
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 15
Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients 15
Bacillus clausii and gut homeostasis: state of the art and future perspectives 15
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 14
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 13
Can we predict the efficacy of anti-TNF-α agents? 13
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease 13
Beyond the HLA Genes in Gluten-Related Disorders 13
COVID-19 and intestinal inflammation: Role of fecal calprotectin 12
Role of Helicobacter pylori infection on nutrition and metabolism 12
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus 12
Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? 11
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 11
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 11
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 10
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 10
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis 10
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 9
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 9
Bariatric procedures and microbiota: patient selection and outcome prediction 9
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 8
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 8
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 8
Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective 8
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn’s Disease: A Prospective Study 8
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” 8
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center 8
Proteobacteria: A common factor in human diseases 7
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 7
Gut microbiota and inflammatory bowel disease: So far so gut! 7
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 7
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 7
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 7
The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors 7
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea 7
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis 7
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 7
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 7
European Crohn's and colitis organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease 7
Abdominal and Bowel Ultrasound Knowledge Among Young Gastroenterologists: Results of an Italian Survey 7
The use of probiotics in different phases of diverticular disease 7
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis 6
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 6
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 5
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 5
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. Pylori infection 5
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 5
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 5
Fecal transplantation for ulcerative colitis: current evidence and future applications 5
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 5
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 4
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 4
Winter Is Coming and COVID-19 Vaccine Is Available! The Role of Gastroenterologist in Increasing COVID-19 Vaccine Acceptability Among IBD Patients 4
Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey 4
The innate and adaptive immune system as targets for biologic therapies in inflammatory bowel disease 4
SARS-CoV-2 infection as a potential trigger factor for de novo occurrence of inflammatory bowel disease 4
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis 4
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 4
Intestinal permeability in physiological and pathological conditions: Major determinants and assessment modalities 4
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 3
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 3
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools 3
Diagnosis of Cholangiocarcinoma: The New Biological and Technological Horizons 3
Diet and Microbiota Modulation for Chronic Pouchitis: Evidence, Challenges, and Opportunities 3
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 3
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 3
Coordinated Multi-Language Translation of A Validated Symptom Questionnaire for Carbohydrate Intolerances: A Practical Structured Procedure 2
Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape 2
Microbiota Composition in Diverticular Disease: Implications for Therapy 2
Totale 1.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202597 0 0 0 0 0 0 0 7 8 29 37 16
2025/20261.219 51 50 105 134 89 47 63 160 212 308 0 0
Totale 1.316